Status:
COMPLETED
Open Label Phase III Duloxetine Study for Stress Urinary Incontinence
Lead Sponsor:
Eli Lilly and Company
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Urinary Incontinence Stress
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.
Eligibility Criteria
Inclusion
- Female out patients
- Are ambulatory and are able to use a toilet independently and without difficulty.
Exclusion
- Use of monoamine oxidase inhibitors (MAOIs)
Key Trial Info
Start Date :
September 1 2001
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
363 Patients enrolled
Trial Details
Trial ID
NCT00191204
Start Date
September 1 2001
End Date
May 1 2006
Last Update
January 26 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours EST), or speak with your personal physician.
Peterborough, United Kingdom, PE3 6JG